Compare

Pandox AB/Skr PNDX B

1D1W1M3M6MYTD1Y5YMAX

About Pandox AB

Pandox AB is a company based in Sweden, operating within the hotel property sector. The company's core business involves the ownership and management of hotel properties across various geographic regions. Pandox AB owns a diverse portfolio of hotel assets that it leases to third-party operators under long-term agreements or manages through its hotel operations segment. Established in 1995, Pandox has a widespread presence in Northern Europe, with a strategic focus on full-service hotels in city center locations. Its competitive advantage lies in its specialized expertise in hotel property management and its extensive network, which enables efficient operations and optimal asset utilization.
Ticker
Skr PNDX B
Primary listing
XSTO
Employees
1,313
Headquarters
Stockholm, Sweden

Pandox AB Metrics

BasicAdvanced
kr 31B
9.87
kr 16.37
1.24
kr 4.50
2.78%

What the Analysts think about Pandox AB

Analyst ratings (Buy, Hold, Sell) for Pandox AB stock.
Analyst projections of the future price of Pandox AB stock.

Bulls say / Bears say

Q2 showed strong earnings momentum: total revenue rose 15%, net operating income 25% and cash earnings per share 15%. The Dalata portfolio added MSEK 312 of rent in the quarter, while EPRA net asset value per share rose 14% year on year. (Nasdaq Stockholm)
Pandox has a sizeable internal growth pipeline. It plans SEK 1.8bn of 2026 investment targeting SEK 170m of stabilised net operating income at a 9.4% yield, alongside more than 600 new rooms due in 2026–27. (Investing.com, Quartr)
The business is supported by diversified European demand and a large lease base. Management reported stable bookings, full event calendars and robust business and leisure demand, while its revenue-based leases include minimum guarantees that can provide downside protection. (Nasdaq Stockholm, Quartr)
Leverage and refinancing remain material risks. Net debt rose 39% year on year, around SEK 8.2bn of debt matures within one year, loan-to-value was 52.4% and interest cover had fallen to 2.4 times. (Investing.com, Quartr)
Reported profit is more volatile than the operating figures suggest. Q2 profit fell 69%, as higher financial costs and weaker property-value changes outweighed the growth in operating income; derivative losses also remain sensitive to interest-rate movements. (Quartr, Fazen Markets)
Growth is uneven across the portfolio and may force a period of balance-sheet consolidation. Germany, the Netherlands and Belgium recorded declining RevPAR, while Nordea said Pandox’s net loan-to-value was at a ten-year high and saw limited scope for positive estimate revisions. (Investing.com, EFN)
Data summarised monthly by Lightyear AI. Last updated on 28 Sept 2026.

Pandox AB Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

Pandox AB Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.